EMFP .69 out with a PR indicating new manufacturing facility to meet the huge demand. Looks positive, at least long term. They have produced a mask which they claim to be better than typical N95 masks as it is used with a nano particle coated filter. Demand is high because of the bird flu scare but no claims are obviously made given the nature of this speculative disease.
There is much more to the company and one needs to read the filings. They have a potential huge market in Japan and with the US military in the area of filtration. Further, a very successful investor has recently taken a major stake in the company. Again, see the filings.
HENDERSON, Nev.--(BUSINESS WIRE)--Dec. 2, 2005-- Emergency Filtration Products, Inc. (EFP) (OTCBB:EMFP) today announced that it has signed a three year lease on a 13,000 square foot facility in Nogales, Mexico, where it intends to establish additional production capabilities to meet increased demand for its NanoMask and NanoMask filters. The Nogales plant will be initially equipped with spray booths to enhance pre-cut filters with nanoparticles, six high speed automatic packaging machines and a filter media cutting machine. EFP expects the Nogales plant to commence production within 4 to 6 weeks. Current plans for the Nogales facility, as in its Henderson, Nevada, plant, are to enhance the filters with nanoparticles and package the filters hermetically. The company sources pre-cut filters from its subcontracted manufacturers where filter media is cut to the company's specifications.
Increasing production capacity is a key component of the company's growth plans, as EFP will then be able to pursue converting serious indications of interest (in the NanoMask and NanoMask filters) from large national and international companies into purchase orders. The company's existing plant in Henderson, Nevada, does not have the production capacity itself to meet the potential demand that has been indicated by a large number of prospective customers. "We are expanding our NanoMask filter production capacity as quickly as possible," said Douglas K. Beplate, President & CEO, EFP. "After meeting with a number of large national and international prospective customers, it became evident that the scale of orders that they are contemplating far outstripped the Henderson facility's production capacity. Accordingly, after reviewing a number of different production options, we decided to establish production in Mexico, which has an ample supply of skilled labor and easy transportation access to the United States and other international locations." The company has recently become aware of certain misleading and inaccurate reports in the media regarding its NanoMask product. In response, the company is taking action to determine the sources of such incorrect information and to proceed as necessary to prevent its dissemination. Accurate and complete information on the NanoMask and EFP's other products is available on the company's website.
EFP's 2H Nano-Enhanced Environmental Mask, the NanoMask relies on the company's core 2H Technology(TM) filtration system, which utilizes a combination of hydrophobic or hydrophilic filters able to capture and isolate bacterial and viral microorganisms with efficiencies of 99.9%. The environmental mask utilizes the company's patented 2H Technology(TM) and nanotechnology to enhance the capture-and-isolation characteristics of the filter media.
EFP is an air filtration products manufacturer who's patented 2H Technology(TM) filter system has produced filtration efficiencies of "greater than 99.99%" at a particulate size of 0.027 microns. Its initial products were developed for the medical market: the Vapor Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for resuscitation of respiratory/cardiac arrest cases; and the 2H Breathing Circuit Filter for ventilators, respirators and anesthesia circuitry. Each has received FDA approval. The company also markets an Automated External Defibrillator Prep Kit featuring RespAide; and the NanoMask(R), a nanotechnology enhanced environmental mask. In addition to filtration products, the company supplies Superstat(R), a modified hemostatic collagen, to the US military for surgery and extreme wound care.
Safe Harbor Statement:
This release may contain statements that are forward looking. Such statements are made based upon current expectations that are subject to risk and uncertainty. EFP does not undertake to update forward-looking statements in this news release to reflect actual results of and changes in assumptions or changes in other factors affecting such forward-looking information. The actual future results of the company could differ significantly from such forward-looking statements. Sales may be dependent on EFP's ability to fulfill orders in a timely fashion as well as the success of future marketing campaigns, the signing of definitive agreements with additional distributors, and both the perceived need for EFP's products and the competitive performance of such products in the marketplace.
KEYWORD: NORTH AMERICA CENTRAL AMERICA NEVADA UNITED STATES MEXICO INDUSTRY KEYWORD: HEALTH MANUFACTURING PRODUCT/SERVICE SOURCE: Emergency Filtration Products, Inc.
CONTACT INFORMATION: Emergency Filtration Products, Inc. Wendy Harper, 702-558-5164 (Fax) 702-567-1893 contactus@emergencyfiltration.com www.emergencyfiltration.com or PAN Consultants, Ltd. Philippe Niemetz, 800-477-7570, 212-344-6464 (Fax) 212-618-1276 p.niemetz@panconsultants.com
Market Data 
Markets 
AI
